Lyell Immunopharma, Inc. financial statements
Lyell Immunopharma, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 36K | 10-K |
| Net income | −USD 274.45M | 10-K |
| Cash and equivalents | USD 60.18M | 10-Q |
| Total debt | USD 50.99M | EODHD |
Lyell Immunopharma, Inc. financials on 6ix · Lyell Immunopharma, Inc. on 6ix